The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
Abstract
CONTEXT: No pharmacological therapeutic protocol has been found effective in modifying the clinical course of acute respiratory distress syndrome (ARDS) and mortality remains greater than 50%. OBJECTIVE: To determine the effects of prolonged methylprednisolone therapy on lung function and mortality in patients with unresolving ARDS. DESIGN: Randomized, double-blind, placebo-controlled trial. SETTING: Medical intensive care units of 4 medical centers. PARTICIPANTS: Twenty-four patients with severe ARDS who had failed to improve lung injury score (LIS) by the seventh day of respiratory failure. INTERVENTIONS: Sixteen patients received methylprednisolone and 8 received placebo. Methylprednisolone dose was initially 2 mg/kg per day and the duration of treatment was 32 days. Four patients whose LIS failed to improve by at least 1 point after 10 days of treatment were blindly crossed over to the alternative treatment. MAIN OUTCOME MEASURES: Primary outcome measures were improvement in lung function and mortality. Secondary outcome measures were improvement in multiple organ dysfunction syndrome (MODS) and development of nosocomial infections. RESULTS: Physiological characteristics at the onset of ARDS were similar in both groups. At study entry (day 9 [SD, 3] of ARDS), the 2 groups had similar LIS, ratios of PaO2 to fraction of inspired oxygen (FIO2), and MODS scores. Changes observed by study day 10 for methylprednisolone vs placebo were as follows: reduced LIS (mean [SEM], 1.7 [0.1] vs 3.0 [0.2]; P<.001); improved ratio of PaO2 to FIO2 (mean [SEM], 262 [19] vs 148 [35]; P<.001); decreased MODS score (mean [SEM], 0.7 [0.2] vs 1.8 [0.3]; P<.001); and successful extubation (7 vs 0; P=.05). For the treatment group vs the placebo group, mortality associated with the intensive care unit was 0 (0%) of 16 vs 5 (62%) of 8 (P=.002) and hospital-associated mortality was 2 (12%) of 16 vs 5 (62%) of 8 (P=.03). The rate of infections per day of treatment was similar in both groups, and pneumonia was frequently detected in the absence of fever. CONCLUSIONS: In this study, prolonged administration of methylprednisolone in patients with unresolving ARDS was associated with improvement in lung injury and MODS scores and reduced mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M., Legall, J. R., Morris, A., & Spragg, R. (1994) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.149.3.7509706 · Cited by 6,746
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
An Expanded Definition of the Adult Respiratory Distress Syndrome
Murray, J. F., Matthay, M. A., Luce, J. M., & Flick, M. R. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.720 · Cited by 2,646
High-Dose Corticosteroids in Patients with the Adult Respiratory Distress Syndrome
Bernard, G. R., Luce, J. M., Sprung, C. L., Rinaldo, J. E., Tate, R. M., Sibbald, W. J., Kariman, K., Higgins, S., Bradley, R., Metz, C. A., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172504 · Cited by 935
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889
Reversal of late septic shock with supraphysiologic doses of hydrocortisone
Bollaert, P.-E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., & Larcan, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00010 · Cited by 872
Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS
Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., & Leeper, K. (1995) · Chest · doi:10.1378/chest.107.4.1062 · Cited by 789
Self-citationInflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695
Self-citation
Cited by
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Ranieri, V. M., Suter, P. M., Tortorella, C., De Tullio, R., Dayer, J. M., Brienza, A., Bruno, F., & Slutsky, A. S. (1999) · JAMA · doi:10.1001/jama.282.1.54 · Cited by 1,908
The acute respiratory distress syndrome
Matthay, M. A., Ware, L. B., & Zimmerman, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60331 · Cited by 1,706
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
De Jonghe, B. (2002) · JAMA · doi:10.1001/jama.288.22.2859 · Cited by 1,516
Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress Syndrome
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa051693 · Cited by 1,498
Contradicted and Initially Stronger Effects in Highly Cited Clinical Research
Ioannidis, J. P. A. (2005) · JAMA · doi:10.1001/jama.294.2.218 · Cited by 1,465
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
“Table S11.”
BackgroundVillar, J., Ferrando, C., Martínez, D., Ambrós, A., Muñoz, T., Soler, J. A., Aguilar, G., Alba, F., González-Higueras, E., Conesa, L. A., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30417-5 · Cited by 1,199
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
Russell, J. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra043632 · Cited by 1,048
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00006 · Cited by 974
“Several of the studies (24, 32, 44, 52) included random or fasting blood glucose levels and the use of diabetic medications in the model with glycosylated hemoglobin; this might be considered “over-adjustment” and probably underestimates the “true” effect of glycemic control (as measured by glycosylated hemoglobin) on…”
BackgroundMethodInfluentialMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
“Recommendation 7: Moderate-dose GC should be considered in the management strategy of patients with early severe ARDS (PaO2/FIO2 of 200) and before day 14 in patients with unresolving ARDS.”
BackgroundInfluentialSelf-citationAcute lung injury and the acute respiratory distress syndrome: a clinical review
Wheeler, A. P., & Bernard, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60604-7 · Cited by 904
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., Della Porta, R., Giorgio, C., Blasi, F., Umberger, R., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-808oc · Cited by 857
Self-citationMethylprednisolone Infusion in Early Severe ARDS
Meduri, G. U., Golden, E., Freire, A. X., Taylor, E., Zaman, M., Carson, S. J., Gibson, M., & Umberger, R. (2007) · Chest · doi:10.1378/chest.06-2100 · Cited by 787
Self-citationAcute Lung Injury: Epidemiology, Pathogenesis, and Treatment
Johnson, E. R., & Matthay, M. A. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0775 · Cited by 783
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Cytokine-mediated inflammation in acute lung injury
Goodman, R. B., Pugin, J., Lee, J. S., & Matthay, M. A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00059-5 · Cited by 688
Matthay, M. A., & Zimmerman, G. A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f305 · Cited by 642
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606
Arabi, Y. M., Arifi, A. A., Balkhy, H. H., Najm, H., Aldawood, A. S., Ghabashi, A., Hawa, H., Alothman, A., Khaldi, A., & Al Raiy, B. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2486 · Cited by 574
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
Annane, D., Bellissant, E., Bollaert, P.-E., Briegel, J., Confalonieri, M., De Gaudio, R., Keh, D., Kupfer, Y., Oppert, M., & Meduri, G. U. (2009) · JAMA · doi:10.1001/jama.2009.815 · Cited by 561
Self-citationPathogenesis of Acute Respiratory Distress Syndrome
Huppert, L., Matthay, M., & Ware, L. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1683996 · Cited by 459
Sepsis—Pathophysiology and Therapeutic Concepts
Jarczak, D., Kluge, S., & Nierhaus, A. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.628302 · Cited by 453
Qadir, N., Sahetya, S., Munshi, L., Summers, C., Abrams, D., Beitler, J., Bellani, G., Brower, R. G., Burry, L., Chen, J.-T., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202311-2011st · Cited by 444
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2004) · BMJ · doi:10.1136/bmj.38181.482222.55 · Cited by 443
The systemic inflammatory response syndrome
Meeran, H., & Messent, M. (2001) · Trauma · doi:10.1177/146040860100300203 · Cited by 425
Extracorporeal Life Support for Severe Acute Respiratory Distress Syndrome in Adults
Hemmila, M. R., Rowe, S. A., Boules, T. N., Miskulin, J., McGillicuddy, J. W., Schuerer, D. J., Haft, J. W., Swaniker, F., Arbabi, S., Hirschl, R. B., et al. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000141159.90676.2d · Cited by 401
The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill
Friedrich, O., Reid, M. B., Van den Berghe, G., Vanhorebeek, I., Hermans, G., Rich, M. M., & Larsson, L. (2015) · Physiological Reviews · doi:10.1152/physrev.00028.2014 · Cited by 396
Chan, J. W. M. (2003) · Thorax · doi:10.1136/thorax.58.8.686 · Cited by 394
ACUTE RESPIRATORY DISTRESS SYNDROME
Conner, B. D., & Bernard, G. R. (2000) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70167-2 · Cited by 382
Annane, D., Pastores, S. M., Rochwerg, B., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4919-5 · Cited by 371
Burnham, E. L., Janssen, W. J., Riches, D. W. H., Moss, M., & Downey, G. P. (2014) · European Respiratory Journal · doi:10.1183/09031936.00196412 · Cited by 365
Why we should be wary of single-center trials
Bellomo, R., Warrillow, S. J., & Reade, M. C. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181bc7bd5 · Cited by 355
Tang, B. M. P., Craig, J. C., Eslick, G. D., Seppelt, I., & McLean, A. S. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819fb507 · Cited by 351
Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome
Brun-Buisson, C., Richard, J.-C. M., Mercat, A., Thiébaut, A. C. M., & Brochard, L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0135oc · Cited by 338
Quality-adjusted Survival in the First Year after the Acute Respiratory Distress Syndrome
ANGUS, D. C., MUSTHAFA, A. A., CLERMONT, G., GRIFFIN, M. F., LINDE-ZWIRBLE, W. T., DREMSIZOV, T. T., & PINSKY, M. R. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.6.2005123 · Cited by 330
Annane, D., Pastores, S. M., Rochwerg, B., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002737 · Cited by 330
Annane, D., Sébille, V., & Bellissant, E. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194723.78632.62 · Cited by 328
Mowery, N. T., Terzian, W. T. H., & Nelson, A. C. (2020) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2020.100777 · Cited by 314
Tsushima, K., King, L. S., Aggarwal, N. R., De Gorordo, A., D'Alessio, F. R., & Kubo, K. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1741 · Cited by 305
Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis
Chaudhuri, D., Sasaki, K., Karkar, A., Sharif, S., Lewis, K., Mammen, M. J., Alexander, P., Ye, Z., Lozano, L. E. C., Munch, M. W., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06394-2 · Cited by 299
Self-citationErickson, S., Schibler, A., Numa, A., Nuthall, G., Yung, M., Pascoe, E., & Wilkins, B. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000269408.64179.ff · Cited by 299
Thille, A. W., Esteban, A., Fernández-Segoviano, P., Rodriguez, J.-M., Aramburu, J.-A., Vargas-Errázuriz, P., Martín-Pellicer, A., Lorente, J. A., & Frutos-Vivar, F. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70053-5 · Cited by 294
Fibroproliferation Occurs Early in the Acute Respiratory Distress Syndrome and Impacts on Outcome
MARSHALL, R. P., BELLINGAN, G., WEBB, S., PUDDICOMBE, A., GOLDSACK, N., McANULTY, R. J., & LAURENT, G. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.5.2001061 · Cited by 285
Comparison of Clinical Criteria for the Acute Respiratory Distress Syndrome with Autopsy Findings
Esteban, A., Fernández-Segoviano, P., Frutos-Vivar, F., Aramburu, J. A., Nájera, L., Ferguson, N. D., Alía, I., Gordo, F., & Ríos, F. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00009 · Cited by 285
Clinical trials in acute respiratory distress syndrome: challenges and opportunities
Matthay, M. A., McAuley, D. F., & Ware, L. B. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30188-1 · Cited by 284
Interventions for preventing critical illness polyneuropathy and critical illness myopathy
Hermans, G., De Jonghe, B., Bruyninckx, F., & Van den Berghe, G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006832.pub3 · Cited by 280
Meduri, G. U., Tolley, E. A., Chrousos, G. P., & Stentz, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2106014 · Cited by 265
Self-citationMeduri, G. U., Bridges, L., Shih, M.-C., Marik, P. E., Siemieniuk, R. A. C., & Kocak, M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-015-4095-4 · Cited by 262
Self-citationActivation and Regulation of Systemic Inflammation in ARDS
Meduri, G. U., Annane, D., Chrousos, G. P., Marik, P. E., & Sinclair, S. E. (2009) · Chest · doi:10.1378/chest.08-2408 · Cited by 260
Self-citationMeduri, G. U., Muthiah, M. P., Carratù, P., Eltorky, M., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000091126 · Cited by 167
Self-citationAdrenal insufficiency in critical illness
Cooper, M. S., & Stewart, P. M. (2007) · Journal of Intensive Care Medicine · doi:10.1177/0885066607307832 · Cited by 97
Mechanical Ventilation and Acute Respiratory Distress Syndrome in Older Patients
Siner, J. M., & Pisani, M. A. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.08.008 · Cited by 16
Metadata
- Authors
- Meduri, G. U., Headley, A. S., Golden, E., Carson, S. J., Umberger, R. A., Kelso, T., & Tolley, E. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1998-07-08
- Volume
- 280
- Issue
- 2
- Pages
- 159
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1999319544
- Cited by
- 1,008
- References
- 31
- FWCI
- 41.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.